Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan
Open Access
- 1 May 2014
- journal article
- research article
- Published by Informa UK Limited in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. 9, 563-8
- https://doi.org/10.2147/copd.s59962
Abstract
Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan Katsuya Onishi,1 Daisuke Yoshimoto,2 Gerry W Hagan,3 Paul W Jones4 1Onishi Heart Clinic, Mie, 2Medical Affairs Respiratory, GlaxoSmithKline KK, Tokyo, Japan; 3Independent Consultant, Marbella, Spain; 4Division of Clinical Science, St George's, University of London, London, UK Background and objectives: Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) commonly coexist and share common risk factors. The prevalence of COPD in outpatients with a smoking history and CVD in Japan is unknown. The aim of this study was to determine the proportion of Japanese patients with a smoking history being treated for CVD who have concurrent airflow limitation compatible with COPD. A secondary objective was to test whether the usage of lung function tests performed in the clinic influenced the diagnosis rate of COPD in the patients identified with airflow limitation. Methods: In a multicenter observational prospective study conducted at 17 centers across Japan, the prevalence of airflow limitation compatible with COPD (defined as forced expiratory volume (FEV)1/FEV6 <0.73, by handheld spirometry) was investigated in cardiac outpatients ≥40 years old with a smoking history who routinely visited the clinic for their CVD. Each patient completed the COPD Assessment Test prior to spirometry testing. Results: Data were available for 995 patients with a mean age of 66.6±10.0 years, of whom 95.5% were male. The prevalence of airflow limitation compatible with COPD was 27.0% (n=269), and 87.7% of those patients (n=236) did not have a prior diagnosis of COPD. The prevalence of previously diagnosed airflow limitation was higher in sites with higher usage of lung function testing (14.0%, 15.2% respectively) compared against sites where it is performed seldom (11.1%), but was still low. Conclusion: The prevalence of airflow limitation in this study indicates that a quarter of outpatients with CVD have COPD, almost all of whom are undiagnosed. This suggests that it is important to look routinely for COPD in CVD outpatients. Keywords: COPD, CVD, handheld spirometer, lung function, diagnosisKeywords
This publication has 27 references indexed in Scilit:
- High Prevalence of Undiagnosed Airflow Limitation in Patients With Cardiovascular DiseaseChest, 2010
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInternational Journal of Chronic Obstructive Pulmonary Disease, 2009
- Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)European Journal of Heart Failure, 2009
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- Prevalence of airflow limitation on medical check-up in Japanese subjects.Journal of UOEH, 2007
- Chronic obstructive pulmonary disease: current burden and future projectionsEuropean Respiratory Journal, 2006
- Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular diseaseCanadian Journal of Physiology and Pharmacology, 2005
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Underdiagnosis and undertreatment of COPD in primary care settingsRespirology, 2003
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyThe Lancet, 1997